FDA clears QbTest for treatment follow-up
The US Food and Drug Administration (FDA) has cleared the neuropsychological test – QbTest – developed by the Swedish company Qbtech to aid in the evaluation of treatment interventions in patients with ADHD.
QbTest is a computer-based test providing clinicians with objective and unbiased decision-making support when diagnosing and treating ADHD in children, adolescents and adults. QbTest is the only test in the world cleared by the FDA for this usage.
Suspendisse ornare massa libero, vel aliquet mi bibendum vel.